Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw a large decline in short interest in July. As of July 31st, there was short interest totaling 114,842 shares, a decline of 40.6% from the July 15th total of 193,488 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 624,752 shares, the days-to-cover ratio is presently 0.2 days.
Fresenius SE & Co. Stock Performance
Shares of Fresenius SE & Co. stock opened at $13.57 on Wednesday. Fresenius SE & Co. has a 12 month low of $10.33 and a 12 month high of $33.93. The company has a current ratio of 1.27, a quick ratio of 0.98 and a debt-to-equity ratio of 0.41. The business has a fifty day simple moving average of $12.28 and a two-hundred day simple moving average of $12.72. The firm has a market capitalization of $30.57 billion, a P/E ratio of 17.18 and a beta of 0.61.
Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a return on equity of 10.33% and a net margin of 6.67%.The company had revenue of $6.91 billion during the quarter, compared to the consensus estimate of $6.65 billion. On average, equities analysts forecast that Fresenius SE & Co. will post 1.08 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Check Out Our Latest Report on Fresenius SE & Co.
Fresenius SE & Co. Company Profile
Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.
The company operates through four main business segments.
See Also
- Five stocks we like better than Fresenius SE & Co.
- Pony AI Stock Gains Traction as Robotaxi Fleet Expands Globally
- Amazon Plugs $18B Into the Southern Power Grid
- Speed Sells: Cerebras Cracks the Silicon Ceiling
- Amid Legal Risks, This Company Is Still Rated a Buy
Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
